Search

everythinglearnresearchcommunity

for

Search:↓

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

UV rays can cause a type of hair loss known as telogen alopecia.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

The article explains how to tell apart and treat two common causes of hair loss in women.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Hair loss increases between July and October, possibly due to UV light, and factors like skin type, hair color, and density may affect this. Dandruff can worsen hair loss conditions.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

Hair loss in women was often caused by stress, illness, childbirth, or low hemoglobin, with most cases being telogen effluvium.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.

Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.

Low vitamin D levels may cause hair loss in women.

Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.

The conclusion is that a brown halo around hair follicles, seen in rapid hair loss, might be linked to inflammation or chemical exposure.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Telogen effluvium most affects quality of life in alopecia patients.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Vitamins and minerals don't significantly affect hair loss treatment in patients with telogen effluvium.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.

Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Sandalore® reduces hair shedding and increases hair volume in women with telogen effluvium.